Cambria Investment Management’s Quest Diagnostics DGX Stock Holding History

Cambria Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-48,958	Closed	-$5.97M	–	294
2023 Q3	$5.97M	Buy	48,958 +3,822	+8%	+$509K	0.48%	106
2023 Q2	$6.34M	Sell	45,136 -1,456	-3%	-$201K	0.53%	97
2023 Q1	$6.59M	Buy	46,592 +4,732	+11%	+$677K	0.54%	92
2022 Q4	$6.55M	Buy	41,860 +6,552	+19%	+$942K	0.55%	80
2022 Q3	$4.33M	Buy	35,308 +2,730	+8%	+$360K	0.47%	89
2022 Q2	$4.33M	Buy	32,578 +3,276	+11%	+$446K	0.56%	87
2022 Q1	$4.01M	Buy	29,302 +9,828	+50%	+$1.37M	0.51%	103
2021 Q4	$3.37M	Buy	19,474 +2,002	+11%	+$305K	0.57%	71
2021 Q3	$2.54M	Buy	+17,472	New	+$2.56M	0.47%	102

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambria Investment Management's DGX Position: Q4 2023 in Review

Cambria Investment Management sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 48,958 shares — an estimated $5.97M sold.

Cambria Investment Management first reported a position in DGX in Q3 2021 and held it in 9 quarters. The position peaked at $6.59M in Q1 2023. 826 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

Cambria Investment Management reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
Cambria Investment Management sold 48,958 Quest Diagnostics shares in Q4 2023, an estimated $5.97M.
Cambria Investment Management first reported a position in Quest Diagnostics in Q3 2021 and held it in 9 quarters.
Cambria Investment Management's Quest Diagnostics position peaked at $6.59M in Q1 2023.
826 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on Cambria Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.